SQUAMOUS CELL CARCINOMA
Clinical trials for SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cancer combo study halted early – what happened?
Disease control TerminatedThis study tested an experimental drug called OC-001, either by itself or together with avelumab (an immunotherapy), in people with advanced cancers that had spread. The goal was to check safety and how the drug moves through the body. The study was stopped early, and only 73 peo…
Matched conditions: SQUAMOUS CELL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Ocellaris Pharma, Inc. • Aim: Disease control
Last updated Jun 12, 2026 12:06 UTC
-
Experimental combo for advanced head and neck cancer shows early safety data
Disease control TerminatedThis early-phase study tested whether adding the immunotherapy drug pembrolizumab to standard chemotherapy and radiation is safe for people with stage IV head and neck cancer. Only 3 participants were enrolled before the study was stopped. The main goal was to find the highest sa…
Matched conditions: SQUAMOUS CELL CARCINOMA
Phase: PHASE1 • Sponsor: Royal Marsden NHS Foundation Trust • Aim: Disease control
Last updated Jun 10, 2026 13:25 UTC
-
Lung cancer biomarker study halted after enrolling only 22 patients
Knowledge-focused TerminatedThis study aimed to find genetic changes in lung tissue and blood that could predict how squamous cell lung cancer progresses. Researchers planned to collect samples from 200 patients undergoing lung procedures, but the study was stopped early with only 22 participants. No treatm…
Matched conditions: SQUAMOUS CELL CARCINOMA
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 16, 2026 22:50 UTC